Against science

Government should not back RSS on GM crops

Image
Business Standard Editorial Comment New Delhi
Last Updated : Jul 31 2014 | 10:01 PM IST
On the very day Prime Minister Narendra Modi asked farm scientists to take technology to fields to boost agricultural output, a couple of Rashtriya Swayamsevak Sangh (RSS)-affiliated organisations said they had prevailed upon his Environment Minister Prakash Javadekar to put on hold decisions on field trials of genetically modified (GM) crops. If so, Mr Javadekar will have committed the same mistake that the United Progressive Alliance government had committed by placing an indefinite moratorium on Bt brinjal after assessing the opinion gathered through public hearings. Fresh freeze on GM trials will jeopardise the fate of nearly two dozen GM crops, including cereals, vegetables and fruit, which have already been approved for field testing by the Genetic Engineering Approval Committee (GEAC) in its last two meetings. About 100 more such GM crops, several of which are non-hybrid varieties that do not require freshly brought seeds every year, are in various stages of development. Huge investment, besides scientific effort, that has gone into their development will go waste.

Two key objections raised by the RSS outfits, such as Swadeshi Jagaran Manch and Bharatiya Kisan Sangh, over GM seeds are that they contain "foreign" genes and that their commercialisation would benefit multinational companies (MNCs). It is distressing that the RSS organisations are trying to influence science policy in this government, because both these pleas are unfounded. Insect-killer Bt gene, for instance, is far from "foreign" as it is derived from a bacterium, Bacillus thuringiensis, present in local soil. The notion that the GM technology is the monopoly of MNCs is also misguided, as a large number of Indian companies and public-sector farm research bodies are also engaged in GM research. In fact, by blocking field trials, the Swadeshi lobby is primarily preventing development of indigenous GM seeds, thereby perpetuating the monopoly of MNC products.

No technical advance is risk-free. GM technology could threaten the environment and health. Its effective regulation and monitoring are imperative. Yes, the present regulatory system does not inspire confidence; and it has been weakened further by shifting the final approval powers from the GEAC to the environment minister. The need, therefore, is to completely rework regulation. Sadly, the well-written Biotechnology Regulatory Authority Bill lapsed with the last Lok Sabha. Instead of taking an anti-science view, the government should move forward with better regulation - and the GM seeds that have already been approved for trials should be rigorously tested for potential risk, not dumped completely.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 31 2014 | 9:38 PM IST

Next Story